CIK 0001385818
- Non-accelerated filer
- Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470883144
- Phone
- +1 720-437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 4 Exercise or conversion Chief Financial Officer acquired 66,666 shares (option exercise)
- 4 Exercise or conversion Director acquired 416,667 shares (option exercise)
- 4 Exercise or conversion Director acquired 37,083 shares (option exercise)
- 4 Exercise or conversion Chief Operating Officer acquired 187,500 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 187,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 33,333 shares at $1.50 ($50,000)
- 4 Open-market buy Chief Financial Officer bought 66,666 shares at $1.50 ($99,999)
- 4 Open-market buy Chief Operating Officer bought 166,666 shares at $1.50 ($249,999)
- 4 Open-market buy Chief Executive Officer bought 166,666 shares at $1.50 ($249,999)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Grant or award Chief Financial Officer acquired 41,899 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 52,374 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 48,184 shares (grant or award)
- 4 Grant or award Director acquired 65,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 65,000 shares (grant or award)
Page 8 of 10 · 187 filings